OVERWEIGHT OR OBESITY
Clinical trials for OVERWEIGHT OR OBESITY explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT OR OBESITY trials appear
Sign up with your email to follow new studies for OVERWEIGHT OR OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New monthly weight-loss jab shows promise in mid-stage trial
Disease control OngoingThis study tests a new medicine called MET097, given as a weekly shot for 12 weeks and then monthly, to see if it helps people with obesity or overweight lose weight safely. About 268 adults who do not have type 2 diabetes will take part. The main goal is to measure weight change…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE2 • Sponsor: Metsera, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 00:58 UTC
-
New weekly shot shows promise for shedding pounds in obesity trial
Disease control OngoingThis study tests a new drug called MET097, given as a weekly shot, to help people with obesity or overweight lose weight. About 225 adults will receive either the drug or a placebo for 28 weeks. The main goal is to see how much weight they lose compared to those on placebo.
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE2 • Sponsor: Metsera, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
New daily pill could ease sleep apnea for people with obesity
Disease control OngoingThis phase 3 trial tests a once-daily medication called orforglipron in 600 adults with moderate-to-severe obstructive sleep apnea (OSA) who are also overweight or have obesity. The study has two parts: one for people who cannot or will not use a CPAP machine, and another for tho…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New Weight-Loss drug candidate enters early human testing
Disease control OngoingThis early-stage study tests the safety of a new drug called IBI3032 in 79 healthy adults who are overweight or obese. Participants receive multiple doses over 4 weeks to see how the drug behaves in the body and if it causes side effects. The goal is to gather initial safety data…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE1 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New daily pill could help millions shed pounds and improve health
Disease control OngoingThis study tests a once-daily oral medication called orforglipron for weight loss in adults with obesity or overweight who also have weight-related conditions like high blood pressure or sleep apnea. About 3,100 participants will take either the drug or a placebo for 72 weeks, wi…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Diet showdown: can fasting beat pills for fatty liver disease?
Disease control ENROLLING_BY_INVITATIONThis study tests whether a Mediterranean diet combined with intermittent fasting can reduce liver scarring better than the weight-loss medication naltrexone/bupropion. About 70 adults with overweight, type 2 diabetes, or other heart-related risks and moderate liver fibrosis will …
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE4 • Sponsor: Carmen Dietvorst • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Sleep apnea treatment may boost diabetes prevention efforts
Prevention OngoingThis study looks at whether adding CPAP (a machine that helps you breathe during sleep) to a lifestyle program can improve blood sugar and blood pressure more than lifestyle changes alone. Researchers are studying 174 overweight or obese adults with prediabetes and sleep apnea. T…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated May 12, 2026 13:40 UTC
-
Berries vs. inflammation: can your gut microbiome be tamed?
Knowledge-focused OngoingThis study looks at how compounds in strawberries and raspberries (polyphenols) interact with gut bacteria to reduce inflammation. Overweight adults with mild inflammation will eat berries or a fiber supplement for 4 weeks. Researchers will measure changes in blood and stool mark…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: NA • Sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology • Aim: Knowledge-focused
Last updated May 17, 2026 00:53 UTC
-
500 obese patients donate samples to unlock secrets of weight loss and regain
Knowledge-focused OngoingThis observational study collects blood, urine, and tissue samples from 500 obese adults to learn more about obesity, weight loss, and why some people regain weight after treatment. Participants must be over 18 and have a BMI of 30 or higher. The samples will be stored for up to …
Matched conditions: OVERWEIGHT OR OBESITY
Sponsor: Pichamol Jirapinyo, MD, MPH • Aim: Knowledge-focused
Last updated May 15, 2026 12:07 UTC
-
Rural PA gets moving: 880-Person study aims to tackle inactivity
Knowledge-focused OngoingThis study looks at ways to help people in rural Pennsylvania become more physically active. It includes 880 adults who are overweight, have type 2 diabetes, or are not active. Researchers will track activity levels using questionnaires and wearable devices to see what works best…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: NA • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated May 13, 2026 16:05 UTC
-
Scientists peer inside the liver to unlock secrets of NASH reversal
Knowledge-focused OngoingThis study looks at how the liver burns fat and produces sugar in people with NASH (a serious fatty liver disease) who are planning to have weight-loss surgery. Researchers will use special scans to measure these liver functions before and after surgery. The goal is to understand…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC
-
Gut health secrets in Low-Carb diet revealed!
TerminatedThis study aimed to see how gut bacteria and blood chemicals change in overweight or obese adults following a special low-carb diet. Participants would provide stool and blood samples as they lost weight. The goal was to understand how diet affects gut health during weight loss.
Matched conditions: OVERWEIGHT OR OBESITY
Sponsor: Westlake University
Last updated Nov 25, 2025 13:45 UTC